Incidence of Major Cardiovascular Events in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease in the General Population

Metabolic dysfunction-associated steatotic liver disease is an independent risk factor for MACE and is associated with a significantly increased risk of all-cause mortality. In the management of patients with cardiovascular risk, identification of MASLD can potentially refine their disease trajectory.

Authors

Institutions

Publication Details

Journal
European Journal of Heart Failure
Published
2025-09-26
DOI
https://doi.org/10.1002/ejhf.70053
Citations
4
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
5.42

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Incidence of Major Cardiovascular Events in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease in the General Population

Philipp S. Wild, Konstantin Strauch, Thomas Muenzel, Manfred E. Beutel et al.
4 citations
European Journal of Heart Failure
Liver Disease Diagnosis and Treatment
5.42
article

Incidence of Major Cardiovascular Events in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease in the General Population

Philipp S. Wild, Konstantin Strauch, Thomas Muenzel, Manfred E. Beutel, Jürgen H. Prochaska, Lea Hofmann, Julian Chalabi, Julia Weinmann‐Menke, Peter R. Galle, Karl J. Lackner, Oliver Tuescher, Yvonne Huber, Jörn M. Schattenberg, Matthias M. Weber, Thomas Koeck, Norbert Pfeiffer
article en
4 citations

Abstract

Metabolic dysfunction-associated steatotic liver disease is an independent risk factor for MACE and is associated with a significantly increased risk of all-cause mortality. In the management of patients with cardiovascular risk, identification of MASLD can potentially refine their disease trajectory.

European Journal of Heart FailureVol. 27(11)
Johannes Gutenberg University Mainz (DE), University Medical Center of the Johannes Gutenberg University Mainz (DE), Institut für Sozialforschung und Sozialwirtschaft (DE), German Centre for Cardiovascular Research (DE), Institute of Molecular Biology (DE), UCB Pharma (Belgium) (BE), Saarland University (DE)
Deutsches Zentrum für Herz-Kreislaufforschung, Bundesministerium für Bildung und Forschung, Stiftung Rheinland-Pfalz für Innovation
Openalex Percentile: Top 4%
Liver Disease Diagnosis and Treatment
5.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.